William G. Wierda, Kathleen Anne Dorritie, Jordan Gauthier, Jacob Drobnyk Soumerai, Saad Kenderian, Rajneesh Nath, Peter A. Riedell, Danielle M. Brander, Daniel Arthur Ermann, Nirav Niranjan Shah, San-San Ou, Sanhita Sengupta, Pradipta Ray, Jixian Wang, Sherilyn Alvaran Tuazon, Revathi Ananthakrishnan, Tanya Siddiqi. "Propensity score (PS) comparison between lisocabtagene maraleucel (liso-cel) plus ibrutinib combination therapy (combo) and liso-cel monotherapy (mono) cohorts from TRANSCEND CLL.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7037